Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.

Journal of genetic counseling - 1 Dec 2022

Weldon Christine B, Trosman Julia R, Liang Su-Ying, Douglas Michael P, Scheuner Maren T, Kurian Allison, Schaa Kendra L, Roscow Breanna, Erwin Deanna, Phillips Kathryn A

Abstract excerpt

Multi-cancer gene panels for hereditary cancer syndromes (hereditary cancer panels, HCPs) are widely available, and some laboratories have programs that limit patients' out-of-pocket (OOP) cost share. However, little is known about practices by cancer genetic counselors for discussing and ordering an HCP and how insurance reimbursement and patient out-of-pocket share impact these practices. We conducted a survey...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, Neoplasm
Share to Genetic Counseling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Neoplastic Syndromes, Hereditary

Share to Surveys and Questionnaires

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 35900261
DOI: 10.1002/jgc4.1614
PMCID: PMC9722528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.PMID 35900261Read ↗

Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.Semantic proximity Read ↗

How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing.Semantic proximity Read ↗

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?Semantic proximity Read ↗

Genetic counselor approaches to BRCA1/2 direct-to-consumer genetic testing results.Semantic proximity Read ↗

"Would you test your children without their consent?" and other sticky dilemmas in the field of cancer genetic testing.Semantic proximity Read ↗

Downstream Revenue Generated by Patients With Hereditary Cancer in the Multigene Panel Testing Era.Semantic proximity Read ↗

Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare ProvidersSemantic proximity Read ↗

Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic CounselingSemantic proximity Read ↗

Cancer Genetic Counseling and Testing in an Era of Rapid Change.Semantic proximity Read ↗

Evaluation of laboratory perspectives on hereditary cancer panels.Semantic proximity Read ↗

Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members.Semantic proximity Read ↗

Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.